Northern Trust Corp Adverum Biotechnologies, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.5 - $2.33 $975 - $1,514	-650 Reduced 0.36%	180,351 $270,000
Q2 2023 Aug 11, 2023	SELL	$0.68 - $1.59 $372 - $871	-548 Reduced 0.3%	181,001 $287,000
Q1 2023 May 15, 2023	SELL	$0.62 - $0.85 $389 - $533	-628 Reduced 0.34%	181,549 $130,000
Q4 2022 Feb 13, 2023	BUY	$0.54 - $10.3 $8,578 - $163,625	15,886 Added 9.55%	182,177 $105,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $3,233 - $32,602	3,368 Added 2.07%	166,291 $158,000
Q2 2022 Aug 12, 2022	SELL	$0.81 - $1.34 $482,482 - $798,180	-595,657 Reduced 78.52%	162,923 $195,000
Q1 2022 May 13, 2022	SELL	$1.23 - $1.95 $39,134 - $62,043	-31,817 Reduced 4.03%	758,580 $994,000
Q4 2021 Feb 08, 2022	SELL	$1.74 - $2.4 $150,931 - $208,180	-86,742 Reduced 9.89%	790,397 $1.39 Million
Q3 2021 Nov 15, 2021	SELL	$2.08 - $3.6 $93,100 - $161,136	-44,760 Reduced 4.86%	877,139 $1.9 Million
Q2 2021 Aug 13, 2021	SELL	$3.36 - $10.56 $199,819 - $628,003	-59,470 Reduced 6.06%	921,899 $3.23 Million
Q1 2021 May 12, 2021	SELL	$9.26 - $14.36 $649,718 - $1.01 Million	-70,164 Reduced 6.67%	981,369 $9.68 Million
Q4 2020 Feb 11, 2021	SELL	$9.84 - $14.26 $93,794 - $135,926	-9,532 Reduced 0.9%	1,051,533 $11.4 Million
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $1.15 Million - $2.43 Million	112,109 Added 11.81%	1,061,065 $10.9 Million
Q2 2020 Aug 14, 2020	BUY	$8.53 - $25.64 $1.26 Million - $3.79 Million	147,757 Added 18.44%	948,956 $19.8 Million
Q1 2020 May 14, 2020	BUY	$7.98 - $16.32 $1.06 Million - $2.16 Million	132,648 Added 19.84%	801,199 $7.83 Million
Q4 2019 Feb 14, 2020	BUY	$5.12 - $12.22 $170,982 - $408,086	33,395 Added 5.26%	668,551 $7.7 Million
Q3 2019 Nov 13, 2019	BUY	$5.24 - $15.89 $169,524 - $514,073	32,352 Added 5.37%	635,156 $3.46 Million
Q2 2019 Aug 13, 2019	SELL	$5.1 - $11.89 $7,665 - $17,870	-1,503 Reduced 0.25%	602,804 $7.17 Million
Q1 2019 May 13, 2019	BUY	$3.03 - $6.02 $118 - $234	39 Added 0.01%	604,307 $3.17 Million
Q4 2018 Feb 12, 2019	SELL	$2.87 - $5.92 $26,645 - $54,961	-9,284 Reduced 1.51%	604,268 $1.9 Million
Q3 2018 Nov 14, 2018	BUY	$4.5 - $7.6 $154,386 - $260,740	34,308 Added 5.92%	613,552 $3.71 Million
Q2 2018 Sep 18, 2018	SELL	$5.3 - $6.9 $21,353 - $27,800	-4,029 Reduced 0.69%	579,244 $3.07 Million
Q2 2018 Aug 14, 2018	BUY	$5.3 - $6.9 $2.56 Million - $3.34 Million	483,435 Added 484.22%	583,273 $3.09 Million
Q1 2018 May 09, 2018	BUY	$3.65 - $7.95 $71,131 - $154,929	19,488 Added 24.25%	99,838 $579,000
Q4 2017 Feb 14, 2018	BUY	$2.85 - $3.95 $76,525 - $106,061	26,851 Added 50.19%	80,350 $281,000
Q3 2017 Nov 13, 2017	BUY	$2.45 - $3.65 $131,072 - $195,271	53,499	53,499 $195,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account